Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use

被引:53
作者
Corvi, R
Ahr, HJ
Albertini, S
Blakey, DH
Clerici, L
Coecke, S
Douglas, GR
Gribaldo, L
Groten, JP
Haase, B
Hamernik, K
Hartung, T
Inoue, T
Indans, I
Maurici, D
Orphanides, G
Rembges, D
Sansone, SA
Snape, JR
Toda, E
Tong, WD
van Delft, JH
Weis, B
Schechtman, LM
机构
[1] Joint Res Ctr European Commiss, European Ctr Validat Alternat Methods, IHCP, I-21120 Ispra, Italy
[2] Bayer HealthCare, Wuppertal, Germany
[3] Hoffmann La Roche AG, Basel, Switzerland
[4] Hlth Canada, Environm Hlth Canada, Ottawa, ON K1A 0L2, Canada
[5] JRC, IHCP, Ispra, Italy
[6] TNO, Utrecht, Netherlands
[7] QIAGEN, Hilden, Germany
[8] US EPA, Washington, DC 20460 USA
[9] Natl Inst Hlth Sci, Tokyo 158, Japan
[10] Hlth Safety Execut, London, England
[11] Syngenta, Macclesfield, Cheshire, England
[12] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England
[13] AstraZeneca, Brixham, England
[14] Org Econ Cooperat & Dev, Paris, France
[15] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[16] Univ Maastricht, Maastricht, Netherlands
[17] NIEHS, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA
[18] US Interagcy Coordinating Comm Validat Alternat M, Res Triangle Pk, NC USA
[19] US FDA, Natl Ctr Toxicol Res, Rockville, MD 20857 USA
关键词
acceptance; alternatives; biomarker; predictive test; regulatory use; standardization; toxicogenomics; toxicology; validation;
D O I
10.1289/ehp.8247
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This is the report of the first workshop "Validation of Toxicogenomics-Based Test Systems" held 11-12 December 2003 in Ispra, Italy. The workshop was hosted by the European Centre for the Validation of Alternative Methods (ECVAM) and organized jointly by ECVAM, the U.S. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). The primary aim of the workshop was for participants to discuss and define principles applicable to the validation of toxicogenomics platforms as well as validation of specific toxicologic test methods that incorporate toxicogenomics technologies. The workshop was viewed as an opportunity for initiating a dialogue between technologic experts, regulators, and the principal validation bodies and for identifying those factors to which the validation process would be applicable. It was felt that to do so now, as the technology is evolving and associated challenges are identified, would be a basis for the future validation of the technology when it reaches the appropriate stage. Because of the complexity of the issue, different aspects of the validation of toxicogenomics-based test methods were covered. The three focus areas include a) biologic validation of toxicogenomics-based test methods for regulatory decision making, b) technical and bioinformatics aspects related to validation, and c) validation issues as they relate to regulatory acceptance and use of toxicogenomics-based test methods. In this report we summarize the discussions and describe in detail the recommendations for future direction and priorities.
引用
收藏
页码:420 / 429
页数:10
相关论文
共 49 条
[1]  
[Anonymous], 2002, Nature, V419, P323
[2]  
Ball C, 2004, ENVIRON HEALTH PERSP, V112, pA666
[3]  
Ball CA, 2002, SCIENCE, V298, P539
[4]  
BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
[5]   Standardizing global gene expression analysis between laboratories and across platforms [J].
Bammler, T ;
Beyer, RP ;
Bhattacharya, S ;
Boorman, GA ;
Boyles, A ;
Bradford, BU ;
Bumgarner, RE ;
Bushel, PR ;
Chaturvedi, K ;
Choi, D ;
Cunningham, ML ;
Dengs, S ;
Dressman, HK ;
Fannin, RD ;
Farun, FM ;
Freedman, JH ;
Fry, RC ;
Harper, A ;
Humble, MC ;
Hurban, P ;
Kavanagh, TJ ;
Kaufmann, WK ;
Kerr, KF ;
Jing, L ;
Lapidus, JA ;
Lasarev, MR ;
Li, J ;
Li, YJ ;
Lobenhofer, EK ;
Lu, X ;
Malek, RL ;
Milton, S ;
Nagalla, SR ;
O'Malley, JP ;
Palmer, VS ;
Pattee, P ;
Paules, RS ;
Perou, CM ;
Phillips, K ;
Qin, LX ;
Qiu, Y ;
Quigley, SD ;
Rodland, M ;
Rusyn, I ;
Samson, LD ;
Schwartz, DA ;
Shi, Y ;
Shin, JL ;
Sieber, SO ;
Slifer, S .
NATURE METHODS, 2005, 2 (05) :351-356
[6]   Pharmacogenomic analysis: Correlating molecular substructure classes with microarray gene expression data [J].
Blower P.E. ;
Yang C. ;
Fligner M.A. ;
Verducci J.S. ;
Yu L. ;
Richman S. ;
Weinstein J.N. .
The Pharmacogenomics Journal, 2002, 2 (4) :259-271
[7]   Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats:: Possible implications for toxicogenomics use of in vitro systems [J].
Boess, F ;
Kamber, M ;
Romer, S ;
Gasser, R ;
Muller, D ;
Albertini, S ;
Suter, L .
TOXICOLOGICAL SCIENCES, 2003, 73 (02) :386-402
[8]   Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].
Brazma, A ;
Hingamp, P ;
Quackenbush, J ;
Sherlock, G ;
Spellman, P ;
Stoeckert, C ;
Aach, J ;
Ansorge, W ;
Ball, CA ;
Causton, HC ;
Gaasterland, T ;
Glenisson, P ;
Holstege, FCP ;
Kim, IF ;
Markowitz, V ;
Matese, JC ;
Parkinson, H ;
Robinson, A ;
Sarkans, U ;
Schulze-Kremer, S ;
Stewart, J ;
Taylor, R ;
Vilo, J ;
Vingron, M .
NATURE GENETICS, 2001, 29 (04) :365-371
[9]   ArrayExpress - a public repository for microarray gene expression data at the EBI [J].
Brazma, A ;
Parkinson, H ;
Sarkans, U ;
Shojatalab, M ;
Vilo, J ;
Abeygunawardena, N ;
Holloway, E ;
Kapushesky, M ;
Kemmeren, P ;
Lara, GG ;
Oezcimen, A ;
Rocca-Serra, P ;
Sansone, SA .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :68-71
[10]  
Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802